Combined High Dose Rate (HDR) Brachytherapy with External Beam Radiotherapy (EBRT) Results in a High Rate of Biochemical Disease Free Survival (DFS) in Localised Intermediate and High Risk Prostate Cancer Patients

被引:0
|
作者
Joseph, N. [1 ]
Taylor, C. [1 ]
Choudhury, A. [1 ]
Elliott, T. [1 ]
Logue, J. [1 ]
Wylie, J. [1 ]
机构
[1] Christie NHS Fdn Trust, Manchester, Lancs, England
关键词
D O I
10.1016/j.clon.2015.12.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E13 / E13
页数:1
相关论文
共 50 条
  • [21] High dose rate brachytherapy boost plus external beam radiotherapy for high risk localized prostate cancer
    Strouthos, I.
    Chatzikonstantinou, G.
    Milickovic, N.
    Papaioannou, S.
    Roedel, C.
    Baltas, D.
    Zamboglou, N.
    Tselis, N.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 : S20 - S20
  • [22] Low and high-dose-rate brachytherapy in combination with external beam radiotherapy for high risk prostate cancer
    Solodkiy, V. A.
    Pavlov, A. Yu
    Tsibulskii, A. D.
    Panshin, G. A.
    Dzidzaria, A. G.
    Mirzahanov, R., I
    ONKOUROLOGIYA, 2021, 17 (02): : 72 - 82
  • [23] Ten Year Survival and Quality of Life after Combined High-Dose-Rate Brachytherapy Boost (HDR-BT) and External Beam Radiotherapy (EBRT) for Localized Prostate Cancer
    Kirste, S.
    Wiedenmann, N.
    Henne, K.
    Bruggmoser, G.
    Knippen, S.
    Volegova, N.
    Schultze-Seemann, W.
    Heinemann, F.
    Grosu, A. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S374 - S374
  • [24] Acute Toxicity after Single Fraction High Dose Rate Brachytherapy with External Beam Radiotherapy in Intermediate and High Risk Prostate Cancer
    Alam, N.
    Taylor, C.
    Mandall, P.
    James, L.
    Logue, J.
    Wylie, J.
    CLINICAL ONCOLOGY, 2009, 21 (10) : 799 - 799
  • [25] Hypoxia and angiogenic biomarkers in prostate cancer after external beam radiotherapy (EBRT) alone or combined with high-dose-rate brachytherapy boost (HDR-BTb)
    Bhattacharya, Indrani S.
    Sharabiani, Mansour Taghavi Azar
    Alonzi, Roberto
    Hoskin, Peter J.
    RADIOTHERAPY AND ONCOLOGY, 2019, 137 : 38 - 44
  • [26] High-dose-rate (HDR) brachytherapy with external beam radiotherapy for localized high-risk prostate cancer: Five-year results in 122 patients.
    Yamamoto, Toshihiro
    Kido, Masahito
    Sasaki, Hiroshi
    Miki, Jun
    Kimura, Takahiro
    Miki, Kenta
    Yamada, Hiroki
    Aoki, Manabu
    Egawa, Shin
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [27] A comprehensive toxicity analysis of 1232 prostate cancer patients treated with pelvic external beam radiotherapy (EBRT) with high dose rate (HDR) brachytherapy boost, adaptive EBRT (ART), or brachytherapy alone (BT)
    Ghilezan, M.
    Kestin, L.
    Gustafson, G.
    Brabbins, D.
    Vicini, F.
    Chen, P.
    Yan, D.
    Martinez, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S59 - S60
  • [28] Results of high dose rate (HDR) brachytherapy boost for prostate cancer
    Kelly, D
    Flynn, J
    Brookover, W
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S18 - S18
  • [29] Long-term biochemical results after high-dose-rate intensity modulated brachytherapy with external beam radiotherapy for high risk prostate cancer
    Prada, Pedro J.
    Mendez, Lucia
    Fernandez, Jose
    Gonzalez, Herminio
    Jimenez, Isabel
    Arrojo, Elisabeth
    RADIATION ONCOLOGY, 2012, 7
  • [30] Long-term biochemical results after high-dose-rate intensity modulated brachytherapy with external beam radiotherapy for high risk prostate cancer
    Pedro J Prada
    Lucia Mendez
    José Fernández
    Herminio González
    Isabel Jiménez
    Elisabeth Arrojo
    Radiation Oncology, 7